SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 246.63 |
| Enterprise Value ($M) | 148.17 |
| Book Value ($M) | 458.52 |
| Book Value / Share | 5.43 |
| Price / Book | 0.54 |
| NCAV ($M) | 454.47 |
| NCAV / Share | 5.38 |
| Price / NCAV | 0.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.38 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.33 |
| Current Ratio | 19.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 486.91 |
| Assets | 490.96 |
| Liabilities | 32.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | BML Investment Partners, L.P. | |||
| 13G/A | EcoR1 Capital, LLC | 6.40 | -22.21 | |
| 13G/A | Fmr Llc | 7.84 | 23.69 | |
| 13G/A | Sommadossi Jean-Pierre | 9.60 | 9.20 | |
| 13G/A | Vanguard Group Inc | 5.51 | -24.47 | |
| 13G/A | BlackRock, Inc. | 11.30 | 6.86 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 56,908 | 204,898 | 27.77 | |
| 74,210 | 359,447 | 20.65 | |
| 34,924 | 216,538 | 16.13 | |
| 42,042 | 435,459 | 9.65 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ASMB – Assembly Biosciences, Inc. | ATHA – Athira Pharma, Inc. |
| ATRA – Atara Biotherapeutics, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. |